4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-24-005758
CEO and Chairman sold 48,673 shares at an average $3.43 ($167,007)
- CEO and Chairman acquired 354,610 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2024-03-04 | Grant or award | +354,610 | 2,625,374 | D | ||
| ROBINS CHAD M CEO and Chairman | 2024-03-05 | Sale | −5,879 | $3.44 | $20,224 | 2,619,495 | D |
| ROBINS CHAD M CEO and Chairman | 2024-03-05 | Sale | −42,794 | $3.43 | $146,783 | 2,576,701 | D |
| Open-market sales · 48,673 sh · avg $3.43 · $167,007 | |||||||
Loading xslF345X05/form4.xml…